Data as of 2:42pm ET
| -0.44 / -1.60%|
The 6 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 42.50, with a high estimate of 52.00 and a low estimate of 35.00. The median estimate represents a +56.88% increase from the last price of 27.09.
The current consensus among 7 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.